These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17579384)

  • 41. Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11).
    Marzola E; Camarda V; Batuwangala M; Lambert DG; Calo' G; Guerrini R; Trapella C; Regoli D; Tomatis R; Salvadori S
    Peptides; 2008 May; 29(5):674-9. PubMed ID: 17822806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and structure-activity relationships of a series of 3-aryl-4-isoxazolecarboxamides as a new class of TGR5 agonists.
    Budzik BW; Evans KA; Wisnoski DD; Jin J; Rivero RA; Szewczyk GR; Jayawickreme C; Moncol DL; Yu H
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1363-7. PubMed ID: 20097073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.
    Igel P; Schneider E; Schnell D; Elz S; Seifert R; Buschauer A
    J Med Chem; 2009 Apr; 52(8):2623-7. PubMed ID: 19317445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b.
    Skinner PJ; Webb PJ; Sage CR; Dang TH; Pride CC; Chen R; Tamura SY; Richman JG; Connolly DT; Semple G
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4207-9. PubMed ID: 19524438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacophore-based design of sphingosine 1-phosphate-3 receptor antagonists that include a 3,4-dialkoxybenzophenone scaffold.
    Koide Y; Uemoto K; Hasegawa T; Sada T; Murakami A; Takasugi H; Sakurai A; Mochizuki N; Takahashi A; Nishida A
    J Med Chem; 2007 Feb; 50(3):442-54. PubMed ID: 17266196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists. Identification, structure-activity relationship, and investigation of binding mode.
    Ulven T; Frimurer TM; Receveur JM; Little PB; Rist O; Nørregaard PK; Högberg T
    J Med Chem; 2005 Sep; 48(18):5684-97. PubMed ID: 16134937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physical association of GPR54 C-terminal with protein phosphatase 2A.
    Evans BJ; Wang Z; Mobley L; Khosravi D; Fujii N; Navenot JM; Peiper SC
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1067-71. PubMed ID: 18977201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids.
    Tanaka T; Nomura W; Narumi T; Esaka A; Oishi S; Ohashi N; Itotani K; Evans BJ; Wang ZX; Peiper SC; Fujii N; Tamamura H
    Org Biomol Chem; 2009 Sep; 7(18):3805-9. PubMed ID: 19707686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, parallel synthesis and SAR of novel urotensin II receptor agonists.
    Lehmann F; Lake L; Currier EA; Olsson R; Hacksell U; Luthman K
    Eur J Med Chem; 2007 Feb; 42(2):276-85. PubMed ID: 17112638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay.
    Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW
    Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative structure-activity analysis of insect kinin core analogs on recombinant kinin receptors from Southern cattle tick Boophilus microplus (Acari: Ixodidae) and mosquito Aedes aegypti (Diptera: Culicidae).
    Taneja-Bageshwar S; Strey A; Zubrzak P; Pietrantonio PV; Nachman RJ
    Arch Insect Biochem Physiol; 2006 Jul; 62(3):128-40. PubMed ID: 16783824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on the structure-activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 1: Tuning the N-substituents.
    Ben L; Jones ED; Zhou E; Li C; Baylis DC; Yu S; Wang M; He X; Coates JA; Rhodes DI; Pei G; Deadman JJ; Xie X; Ma D
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4012-4. PubMed ID: 20561788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and evaluation of novel phenoxypropanolamine derivatives containing acetanilides as potent and selective beta3-adrenergic receptor agonists.
    Maruyama T; Onda K; Hayakawa M; Seki N; Takahashi T; Moritomo H; Suzuki T; Matsui T; Takasu T; Nagase I; Ohta M
    Bioorg Med Chem; 2009 May; 17(9):3283-94. PubMed ID: 19362005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptor.
    Shen HC; Ding FX; Luell S; Forrest MJ; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Wilsie LC; Krsmanovic ML; Taggart AK; Ren N; Cai TQ; Deng Q; Chen Q; Wang J; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
    J Med Chem; 2007 Dec; 50(25):6303-6. PubMed ID: 17994679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of diacylphloroglucinols as a new class of GPR40 (FFAR1) agonists.
    Bharate SB; Rodge A; Joshi RK; Kaur J; Srinivasan S; Kumar SS; Kulkarni-Almeida A; Balachandran S; Balakrishnan A; Vishwakarma RA
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6357-61. PubMed ID: 18993064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracellular signaling pathways activated by kisspeptins through GPR54: do multiple signals underlie function diversity?
    Castaño JP; Martínez-Fuentes AJ; Gutiérrez-Pascual E; Vaudry H; Tena-Sempere M; Malagón MM
    Peptides; 2009 Jan; 30(1):10-5. PubMed ID: 18775460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.
    Diaz P; Xu J; Astruc-Diaz F; Pan HM; Brown DL; Naguib M
    J Med Chem; 2008 Aug; 51(16):4932-47. PubMed ID: 18666769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. End-capping of the modified melanocortin tetrapeptide (p-Cl)Phe-D-Phe-Arg-Trp-NH2 as a route to hMC4R agonists.
    Koikov LN; Ebetino FH; Hayes JC; Cross-Doersen D; Knittel JJ
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4839-42. PubMed ID: 15341935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.
    Igel P; Geyer R; Strasser A; Dove S; Seifert R; Buschauer A
    J Med Chem; 2009 Oct; 52(20):6297-313. PubMed ID: 19791743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis, and biological evaluation of novel investigational nonapeptide KISS1R agonists with testosterone-suppressive activity.
    Asami T; Nishizawa N; Matsui H; Nishibori K; Ishibashi Y; Horikoshi Y; Nakayama M; Matsumoto S; Tarui N; Yamaguchi M; Matsumoto H; Ohtaki T; Kitada C
    J Med Chem; 2013 Nov; 56(21):8298-307. PubMed ID: 24047141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.